Ms. Maryana Salamah | Pharmaceutical Sciences | Best Researcher Award
Ph.D student at University of Szeged | Hungary
Ms. Maryana Salamah is a Syrian researcher and academic specializing in pharmaceutical sciences with strong expertise in pharmaceutical chemistry, drug quality control, and nanomedicine. She has served as a laboratory supervisor at several universities, where she taught and illustrated experiments in areas such as pharmacognosy, pharmacology, industrial pharmacy, drug quality control, biopharmacy, and pharmacokinetics. Her professional background also includes work as a medical representative in the pharmaceutical industry and as a practicing pharmacist, which gave her extensive practical knowledge of medicines, drug formulations, and patient care. She later advanced her academic career by pursuing higher studies and research, focusing on innovative pharmaceutical technologies and drug delivery systems. Her research output includes 16 citations across 16 documents, with 5 published papers and an h-index of 3, reflecting her growing impact in the scientific community. She has presented her findings at numerous international conferences and symposia across Europe and the Middle East, engaging with the wider scientific community on pharmaceutical technology, biotechnology, regulatory science, and medicinal chemistry. Her involvement in various scientific forums highlights her active contribution to advancing knowledge in drug development and regulatory standards.
Featured Publications:
Salamah, M., Sipos, B., Katona, G., Volk, B., Balogh, G. T., & Csóka, I. (2025). Development and validation of a novel isocratic RP-HPLC method using AQbD approach for the quantification of Favipiravir. European Journal of Pharmaceutical Sciences.
Salamah, M., Volk, B., Lekli, I., Bak, I., Gyöngyösi, A., Kozma, G., Kónya, Z., Szalenkó-Tőkés, Á., Kiricsi, Á., Rovó, L., Balogh-Weiser, D., Zupkó, I., Csóka, I., Katona, G., & Balogh, G. T. (2025). Preparation, and ex vivo and in vivo characterization of Favipiravir-loaded aspasomes and niosomes for nose-to-brain administration. International Journal of Nanomedicine, 20, 6489–6514.
Salamah, M., Sipos, B., Schelz, Z., Zupkó, I., Kiricsi, Á., Szalenkó-Tőkés, Á., Rovó, L., Katona, G., Balogh, G. T., & Csóka, I. (2025). Development, in vitro and ex vivo characterization of lamotrigine-loaded bovine serum albumin nanoparticles using QbD approach. Drug Delivery, 32(1), 2460693.
Salamah, M., Budai-Szűcs, M., Sipos, B., Volk, B., Katona, G., Balogh, G. T., & Csóka, I. (2025). Development and characterization of in situ gelling nasal cilostazol spanlastics. Gels, 11(2), 82.
Balogh-Weiser, D., Molnár, A., Tóth, G. D., Koplányi, G., Szemes, J., Decsi, B., Katona, G., Salamah, M., Ender, F., Kovács, A., Berkó, S., Budai-Szűcs, M., & Balogh, G. T. (2023). Combined nanofibrous face mask: Co-formulation of lipases and antibiotic agent by electrospinning technique. Pharmaceutics, 15(4), 1174.